Nicorandil v placebo for stable angina with additional risk factors†
| Outcomes at 1 to 3 years | Nicorandil | Placebo | RRR (95% CI) | NNT (CI) |
|---|---|---|---|---|
| †Composite 1 = coronary heart disease death, nonfatal myocardial infarction, or unplanned hospital admission for chest pain; composite 2 = coronary heart disease death or nonfatal myocardial infarction. Other abbreviations defined in Glossary; RRR, NNT, and CI calculated from data in article. | ||||
| Composite 1 | 13.1% | 15.5% | 16% (3 to 26) | 41 (25 to 234) |
| Composite 2 | 4.2% | 5.2% | 21% (–2 to 38) | Not significant |